NASDAQ:ABUS   Arbutus Biopharma Corporation
$3.60 arrea was heavy resistance, now it's strong support.
Touching trend line and Over sold
RSI tuning green, prepping for another run up.

Yahoo Finance says it's 26% under valued.

Looks like a decent entry point with a SL below $3.60
Heavy Resistance at $4.50 and could turn into a H+S

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。